Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients
N/A
Serum FGF-23 levels will be measured in patients with a history of coronary...
Status
Unknown
Location
Diskapi Training and Research Hospital
Start Date
2009-12
Trial ID
NCT01154842
Effect of rEPO in FGF23 in ESRD Patients
N/A
Objective: To evaluate the effects of recombinant Erythropoietin (rEPO) in ...